Journal of Medicinal Chemistry · 2011 · 61 citations · 27 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsDe Novo Drug DesignEnzyme InhibitionLigand BindingLigand-based DesignPotency OptimizationSelectivity DesignHydration OptimizationKinase Inhibitor Library DesignKinase Selectivity ProfilingSelectivitySelectivity Profile OptimizationStructure-based De Novo DesignStructure-based Selectivity DesignT Cell Effector Functions
Interleukin-2 inducible T-cell kinase (Itk) plays a role in T-cell functions, and its inhibition potentially represents an attractive intervention point to treat autoimmune and allergic diseases. Herein we describe the discovery of a series of potent and selective novel inhibitors of Itk. These inhibitors were identified by structure-based design, starting from a fragment generated de novo, the 3-aminopyrid-2-one motif. Functionalization of the 3-amino group enabled rapid enhancement of the inhibitory activity against Itk, while introduction of a substituted heteroaromatic ring in position 5 of the pyridone fragment was key to achieving optimal selectivity over related kinases. A careful analysis of the hydration patterns in the kinase active site was necessary to fully explain the observed selectivity profile. The best molecule prepared in this optimization campaign, 7v, inhibits Itk with a K(i) of 7 nM and has a good selectivity profile across kinases.
27
How good is fluorine as a hydrogen bond acceptor?
Judith A. K. Howard, Vanessa J. Hoy, David O’Hagan et al. · Tetrahedron · 1996 · 729 citations
The Structural Basis for Autoinhibition of FLT3 by the Juxtamembrane Domain
James Griffith, James Black, Carlos H. Faerman et al. · Molecular Cell · 2004 · 500 citations · Full text
Requirement for Tec Kinases Rlk and Itk in T Cell Receptor Signaling and Immunity
Edward M. Schaeffer, Jayanta Debnath, George Yap et al. · Science · 1999 · 401 citations